Polychem Ltd
Incorporated in 1956, Polychem Ltd is
in the business of manufacturing of specialty chemicals and property development[1]
- Market Cap ₹ 90.5 Cr.
- Current Price ₹ 2,263
- High / Low ₹ 3,725 / 1,950
- Stock P/E 16.0
- Book Value ₹ 812
- Dividend Yield 1.33 %
- ROCE 26.2 %
- ROE 20.7 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has delivered good profit growth of 53.6% CAGR over last 5 years
- Debtor days have improved from 60.9 to 39.4 days.
Cons
- Earnings include an other income of Rs.3.24 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9.47 | 15.03 | 17.79 | 12.63 | 14.39 | 16.27 | 18.91 | 23.01 | 10.94 | 20.42 | 35.22 | 36.87 | 31.03 | |
10.81 | 14.40 | 16.73 | 12.93 | 14.99 | 17.00 | 18.90 | 20.08 | 11.37 | 20.63 | 30.39 | 29.49 | 26.31 | |
Operating Profit | -1.34 | 0.63 | 1.06 | -0.30 | -0.60 | -0.73 | 0.01 | 2.93 | -0.43 | -0.21 | 4.83 | 7.38 | 4.72 |
OPM % | -14.15% | 4.19% | 5.96% | -2.38% | -4.17% | -4.49% | 0.05% | 12.73% | -3.93% | -1.03% | 13.71% | 20.02% | 15.21% |
1.04 | 1.04 | 0.72 | 1.08 | 1.45 | 0.83 | 0.87 | 0.72 | 1.29 | 3.87 | 0.46 | 1.28 | 3.24 | |
Interest | 0.02 | 0.04 | 0.00 | 0.00 | 0.04 | 0.01 | 0.00 | 0.03 | 0.07 | 0.05 | 0.14 | 0.13 | 0.12 |
Depreciation | 0.11 | 0.14 | 0.30 | 0.23 | 0.18 | 0.19 | 0.18 | 0.51 | 0.51 | 0.47 | 0.55 | 0.82 | 0.80 |
Profit before tax | -0.43 | 1.49 | 1.48 | 0.55 | 0.63 | -0.10 | 0.70 | 3.11 | 0.28 | 3.14 | 4.60 | 7.71 | 7.04 |
Tax % | 9.30% | 4.03% | 35.81% | 23.64% | -30.16% | 40.00% | 0.00% | 22.51% | -7.14% | -3.18% | 19.13% | 21.66% | |
-0.47 | 1.44 | 0.94 | 0.42 | 0.83 | -0.14 | 0.70 | 2.41 | 0.29 | 3.23 | 3.72 | 6.04 | 5.64 | |
EPS in Rs | -11.63 | 35.64 | 23.27 | 10.40 | 20.54 | -3.47 | 17.33 | 59.65 | 7.18 | 79.95 | 92.08 | 149.50 | 139.59 |
Dividend Payout % | 0.00% | 0.00% | 10.64% | 23.81% | 12.05% | 0.00% | 14.29% | 20.75% | 0.00% | 3.72% | 21.51% | 19.87% |
Compounded Sales Growth | |
---|---|
10 Years: | 9% |
5 Years: | 14% |
3 Years: | 50% |
TTM: | -4% |
Compounded Profit Growth | |
---|---|
10 Years: | 20% |
5 Years: | 54% |
3 Years: | 172% |
TTM: | 25% |
Stock Price CAGR | |
---|---|
10 Years: | 14% |
5 Years: | 49% |
3 Years: | 66% |
1 Year: | -3% |
Return on Equity | |
---|---|
10 Years: | 9% |
5 Years: | 14% |
3 Years: | 17% |
Last Year: | 21% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 0.40 | 0.40 | 0.40 | 0.40 | 0.40 | 0.40 | 0.40 | 0.40 | 0.40 | 0.40 | 0.40 | 0.40 | 0.40 |
Reserves | 13.51 | 14.95 | 15.77 | 16.07 | 17.13 | 16.85 | 17.53 | 19.77 | 19.58 | 22.77 | 26.31 | 31.48 | 32.39 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.41 | 1.22 | 0.19 | |
1.42 | 2.41 | 1.21 | 1.19 | 1.59 | 1.84 | 1.86 | 2.78 | 2.23 | 3.58 | 3.14 | 2.24 | 3.10 | |
Total Liabilities | 15.33 | 17.76 | 17.38 | 17.66 | 19.12 | 19.09 | 19.79 | 22.95 | 22.21 | 26.75 | 30.26 | 35.34 | 36.08 |
0.50 | 0.69 | 0.64 | 0.54 | 0.42 | 0.54 | 0.97 | 1.42 | 1.14 | 0.75 | 1.98 | 2.48 | 2.33 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 4.88 | 1.44 | 3.44 | 3.33 | 4.05 | 4.23 | 8.59 | 9.28 | 11.30 | 14.88 | 16.49 | 18.09 | 21.73 |
9.95 | 15.63 | 13.30 | 13.79 | 14.65 | 14.32 | 10.23 | 12.25 | 9.77 | 11.12 | 11.79 | 14.77 | 12.02 | |
Total Assets | 15.33 | 17.76 | 17.38 | 17.66 | 19.12 | 19.09 | 19.79 | 22.95 | 22.21 | 26.75 | 30.26 | 35.34 | 36.08 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-4.17 | -4.32 | 1.85 | 0.41 | -0.13 | -0.85 | -0.95 | 2.81 | 0.75 | -2.31 | 4.49 | 3.97 | |
3.54 | 4.08 | -1.52 | 0.24 | 0.27 | 1.35 | 0.43 | -0.74 | 0.80 | -0.44 | -3.03 | -2.41 | |
-0.02 | -0.03 | 0.00 | -0.10 | -0.10 | -0.11 | 0.00 | -0.34 | -0.76 | -0.24 | -0.37 | -1.09 | |
Net Cash Flow | -0.65 | -0.27 | 0.33 | 0.55 | 0.04 | 0.38 | -0.51 | 1.73 | 0.80 | -2.99 | 1.08 | 0.46 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 90.19 | 97.62 | 45.96 | 68.20 | 60.37 | 72.69 | 71.03 | 64.56 | 94.42 | 109.75 | 33.47 | 39.40 |
Inventory Days | 116.82 | 82.62 | 75.82 | 120.45 | 90.83 | 77.73 | 73.13 | 69.91 | 145.58 | 74.97 | 88.71 | 90.35 |
Days Payable | 50.87 | 71.67 | 18.34 | 38.06 | 39.95 | 46.64 | 29.19 | 25.36 | 52.94 | 48.92 | 26.06 | 11.74 |
Cash Conversion Cycle | 156.15 | 108.57 | 103.44 | 150.59 | 111.25 | 103.78 | 114.97 | 109.10 | 187.06 | 135.80 | 96.13 | 118.01 |
Working Capital Days | 218.54 | 245.76 | 196.14 | 262.12 | 228.03 | 196.52 | 116.78 | 72.97 | 122.78 | 105.82 | 60.11 | 74.15 |
ROCE % | -7.77% | 7.59% | 9.39% | 3.37% | 4.00% | -0.46% | 4.04% | 16.64% | 1.79% | 14.60% | 18.97% | 26.17% |
Documents
Announcements
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 15 Nov
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
15 Nov - Newspaper Publication of Standalone and Consolidated Unaudited Financial Results for the quarter and half year ended September 30, 2024
-
Standalone And Consolidated Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2024
13 Nov - Approval of standalone and consolidated financial results.
-
Board Meeting Outcome for Standalone And Consolidated Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2024
13 Nov - Approval of standalone and consolidated financial results.
-
Board Meeting Intimation for To Consider The Standalone And Consolidated Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2024
5 Nov - Board meeting to approve Q2 financial results.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Product Profile:[1]
a) Polystyren:[2]
Cross Linked Polystyrene is a co-polymer
of Styrene & Di Vinyl Benzene which is used
in investment casting, corrosive and marine paints, pharmaceutical formulations, etc.
b) LMPS:[3]
LMPS is a low molecular weight homopolymer of Styrene. It finds applications in precision casting, printing inks, SMC & DMC compounds, microcellular soles & Hawai chappals, PVC extrusion compounds, etc.
c) Acrylate-C:[4]
It is a copolymer of Styrene & Ethyl Acrylate used in Concrete curing & sealing, waterproofing compounds, metal coating formulations, etc.
d) SBA PC - 30 / 50:[5]
It is an emulsion of an Acrylic Co-polymer
used as an additive for modifying cement
mortar /concrete